ID PSA3_RAT Reviewed; 255 AA. AC P18422; DT 01-NOV-1990, integrated into UniProtKB/Swiss-Prot. DT 23-JAN-2007, sequence version 3. DT 27-MAR-2024, entry version 189. DE RecName: Full=Proteasome subunit alpha type-3; DE AltName: Full=Macropain subunit C8; DE AltName: Full=Multicatalytic endopeptidase complex subunit C8; DE AltName: Full=Proteasome component C8; DE AltName: Full=Proteasome subunit K; GN Name=Psma3; OS Rattus norvegicus (Rat). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Rattus. OX NCBI_TaxID=10116; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE. RC TISSUE=Liver; RX PubMed=2249692; DOI=10.1111/j.1432-1033.1990.tb19399.x; RA Sorimachi H., Tsukahara T., Kawasaki H., Ishiura S., Emori Y., Sugita H., RA Suzuki K.; RT "Molecular cloning of cDNAs for two subunits of rat multicatalytic RT proteinase. Existence of N-terminal conserved and C-terminal diverged RT sequences among subunits."; RL Eur. J. Biochem. 193:775-781(1990). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=2403356; DOI=10.1016/0006-291x(90)91199-3; RA Tanaka K., Kanayama H., Tamura T., Lee D.H., Kumatori A., Fujiwara T., RA Ichihara A., Tokunaga F., Aruga R., Iwanaga S.; RT "cDNA cloning and sequencing of component C8 of proteasomes from rat RT hepatoma cells."; RL Biochem. Biophys. Res. Commun. 171:676-683(1990). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Kidney; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP PROTEIN SEQUENCE OF 2-29, CLEAVAGE OF INITIATOR METHIONINE, AND ACETYLATION RP AT SER-2. RC TISSUE=Liver; RX PubMed=2335242; DOI=10.1016/0014-5793(90)81417-m; RA Tokunaga F., Aruga R., Iwanaga S., Tanaka K., Ichihara A., Takao T., RA Shimonishi Y.; RT "The NH2-terminal residues of rat liver proteasome (multicatalytic RT proteinase complex) subunits, C2, C3 and C8, are N alpha-acetylated."; RL FEBS Lett. 263:373-375(1990). RN [5] RP PROTEIN SEQUENCE OF 30-41; 44-52; 67-93; 101-110 AND 197-206, AND RP IDENTIFICATION BY MASS SPECTROMETRY. RC STRAIN=Sprague-Dawley; TISSUE=Hippocampus; RA Lubec G., Chen W.-Q.; RL Submitted (APR-2007) to UniProtKB. RN [6] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-250, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=16641100; DOI=10.1073/pnas.0600895103; RA Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.; RT "Quantitative phosphoproteomics of vasopressin-sensitive renal cells: RT regulation of aquaporin-2 phosphorylation at two sites."; RL Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006). RN [7] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243 AND SER-250, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=22673903; DOI=10.1038/ncomms1871; RA Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C., RA Olsen J.V.; RT "Quantitative maps of protein phosphorylation sites across 14 different rat RT organs and tissues."; RL Nat. Commun. 3:876-876(2012). CC -!- FUNCTION: Component of the 20S core proteasome complex involved in the CC proteolytic degradation of most intracellular proteins. This complex CC plays numerous essential roles within the cell by associating with CC different regulatory particles. Associated with two 19S regulatory CC particles, forms the 26S proteasome and thus participates in the ATP- CC dependent degradation of ubiquitinated proteins. The 26S proteasome CC plays a key role in the maintenance of protein homeostasis by removing CC misfolded or damaged proteins that could impair cellular functions, and CC by removing proteins whose functions are no longer required. Associated CC with the PA200 or PA28, the 20S proteasome mediates ubiquitin- CC independent protein degradation. This type of proteolysis is required CC in several pathways including spermatogenesis (20S-PA200 complex) or CC generation of a subset of MHC class I-presented antigenic peptides CC (20S-PA28 complex). Binds to the C-terminus of CDKN1A and thereby CC mediates its degradation. Negatively regulates the membrane trafficking CC of the cell-surface thromboxane A2 receptor (TBXA2R) isoform 2. CC {ECO:0000250|UniProtKB:P25788}. CC -!- SUBUNIT: The 26S proteasome consists of a 20S proteasome core and two CC 19S regulatory subunits. The 20S proteasome core is a barrel-shaped CC complex made of 28 subunits that are arranged in four stacked rings. CC The two outer rings are each formed by seven alpha subunits, and the CC two inner rings are formed by seven beta subunits. The proteolytic CC activity is exerted by three beta-subunits PSMB5, PSMB6 and PSMB7. CC Interacts with AURKB. Interacts with CDKN1A. Interacts with MDM2 and CC RB1. Interacts with the C-terminus of TBXA2R isoform 2. Interacts with CC DNAJB2. {ECO:0000250|UniProtKB:P25788}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P25788}. Nucleus CC {ECO:0000250|UniProtKB:P25788}. Note=Translocated from the cytoplasm CC into the nucleus following interaction with AKIRIN2, which bridges the CC proteasome with the nuclear import receptor IPO9. CC {ECO:0000250|UniProtKB:P25788}. CC -!- TISSUE SPECIFICITY: Ubiquitous. CC -!- SIMILARITY: Belongs to the peptidase T1A family. {ECO:0000255|PROSITE- CC ProRule:PRU00808}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X55985; CAA39457.1; -; mRNA. DR EMBL; D90258; BAA14302.1; -; mRNA. DR EMBL; M58593; AAA40840.1; -; mRNA. DR EMBL; BC081817; AAH81817.1; -; mRNA. DR PIR; S14004; SNRTC8. DR RefSeq; NP_001004094.1; NM_001004094.1. DR RefSeq; NP_058976.1; NM_017280.2. DR PDB; 6EPC; EM; 12.30 A; G=1-255. DR PDB; 6EPD; EM; 15.40 A; G=1-255. DR PDB; 6EPE; EM; 12.80 A; G=1-255. DR PDB; 6EPF; EM; 11.80 A; G=1-255. DR PDB; 6TU3; EM; 2.70 A; G/U=1-255. DR PDBsum; 6EPC; -. DR PDBsum; 6EPD; -. DR PDBsum; 6EPE; -. DR PDBsum; 6EPF; -. DR PDBsum; 6TU3; -. DR AlphaFoldDB; P18422; -. DR EMDB; EMD-10586; -. DR EMDB; EMD-3913; -. DR EMDB; EMD-3914; -. DR EMDB; EMD-3915; -. DR EMDB; EMD-3916; -. DR SMR; P18422; -. DR BioGRID; 248291; 5. DR BioGRID; 268414; 1. DR STRING; 10116.ENSRNOP00000010753; -. DR iPTMnet; P18422; -. DR PhosphoSitePlus; P18422; -. DR jPOST; P18422; -. DR PaxDb; 10116-ENSRNOP00000010753; -. DR Ensembl; ENSRNOT00000105733.1; ENSRNOP00000084525.1; ENSRNOG00000007851.7. DR Ensembl; ENSRNOT00055016021; ENSRNOP00055012856; ENSRNOG00055009458. DR Ensembl; ENSRNOT00060011098; ENSRNOP00060008290; ENSRNOG00060006748. DR Ensembl; ENSRNOT00065011258; ENSRNOP00065008217; ENSRNOG00065007205. DR GeneID; 29670; -. DR GeneID; 408248; -. DR KEGG; rno:29670; -. DR UCSC; RGD:61844; rat. DR AGR; RGD:1598236; -. DR AGR; RGD:61844; -. DR CTD; 408248; -. DR CTD; 5684; -. DR RGD; 61844; Psma3. DR eggNOG; KOG0184; Eukaryota. DR GeneTree; ENSGT00550000074912; -. DR HOGENOM; CLU_035750_0_0_1; -. DR InParanoid; P18422; -. DR OMA; RVSMYMH; -. DR OrthoDB; 166567at2759; -. DR PhylomeDB; P18422; -. DR TreeFam; TF106208; -. DR Reactome; R-RNO-1169091; Activation of NF-kappaB in B cells. DR Reactome; R-RNO-1234176; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha. DR Reactome; R-RNO-1236978; Cross-presentation of soluble exogenous antigens (endosomes). DR Reactome; R-RNO-174084; Autodegradation of Cdh1 by Cdh1:APC/C. DR Reactome; R-RNO-174113; SCF-beta-TrCP mediated degradation of Emi1. DR Reactome; R-RNO-174154; APC/C:Cdc20 mediated degradation of Securin. DR Reactome; R-RNO-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1. DR Reactome; R-RNO-174184; Cdc20:Phospho-APC/C mediated degradation of Cyclin A. DR Reactome; R-RNO-187577; SCF(Skp2)-mediated degradation of p27/p21. DR Reactome; R-RNO-195253; Degradation of beta-catenin by the destruction complex. DR Reactome; R-RNO-2467813; Separation of Sister Chromatids. DR Reactome; R-RNO-349425; Autodegradation of the E3 ubiquitin ligase COP1. DR Reactome; R-RNO-350562; Regulation of ornithine decarboxylase (ODC). DR Reactome; R-RNO-382556; ABC-family proteins mediated transport. DR Reactome; R-RNO-450408; AUF1 (hnRNP D0) binds and destabilizes mRNA. DR Reactome; R-RNO-4608870; Asymmetric localization of PCP proteins. DR Reactome; R-RNO-4641257; Degradation of AXIN. DR Reactome; R-RNO-4641258; Degradation of DVL. DR Reactome; R-RNO-5358346; Hedgehog ligand biogenesis. DR Reactome; R-RNO-5607761; Dectin-1 mediated noncanonical NF-kB signaling. DR Reactome; R-RNO-5610780; Degradation of GLI1 by the proteasome. DR Reactome; R-RNO-5610785; GLI3 is processed to GLI3R by the proteasome. DR Reactome; R-RNO-5632684; Hedgehog 'on' state. DR Reactome; R-RNO-5658442; Regulation of RAS by GAPs. DR Reactome; R-RNO-5668541; TNFR2 non-canonical NF-kB pathway. DR Reactome; R-RNO-5676590; NIK-->noncanonical NF-kB signaling. DR Reactome; R-RNO-5687128; MAPK6/MAPK4 signaling. DR Reactome; R-RNO-5689603; UCH proteinases. DR Reactome; R-RNO-5689880; Ub-specific processing proteases. DR Reactome; R-RNO-68867; Assembly of the pre-replicative complex. DR Reactome; R-RNO-68949; Orc1 removal from chromatin. DR Reactome; R-RNO-69017; CDK-mediated phosphorylation and removal of Cdc6. DR Reactome; R-RNO-69481; G2/M Checkpoints. DR Reactome; R-RNO-69601; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A. DR Reactome; R-RNO-75815; Ubiquitin-dependent degradation of Cyclin D. DR Reactome; R-RNO-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint. DR Reactome; R-RNO-8854050; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis. DR Reactome; R-RNO-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs. DR Reactome; R-RNO-8941858; Regulation of RUNX3 expression and activity. DR Reactome; R-RNO-8948751; Regulation of PTEN stability and activity. DR Reactome; R-RNO-8951664; Neddylation. DR Reactome; R-RNO-9755511; KEAP1-NFE2L2 pathway. DR Reactome; R-RNO-9762114; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2. DR Reactome; R-RNO-983168; Antigen processing: Ubiquitination & Proteasome degradation. DR PRO; PR:P18422; -. DR Proteomes; UP000002494; Chromosome 6. DR Bgee; ENSRNOG00000007851; Expressed in ovary and 20 other cell types or tissues. DR GO; GO:0005737; C:cytoplasm; ISO:RGD. DR GO; GO:0005634; C:nucleus; ISO:RGD. DR GO; GO:0000502; C:proteasome complex; ISO:RGD. DR GO; GO:0005839; C:proteasome core complex; ISS:UniProtKB. DR GO; GO:0019773; C:proteasome core complex, alpha-subunit complex; ISS:UniProtKB. DR GO; GO:0045202; C:synapse; IDA:SynGO. DR GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:RGD. DR GO; GO:0010498; P:proteasomal protein catabolic process; IBA:GO_Central. DR GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro. DR CDD; cd03751; proteasome_alpha_type_3; 1. DR Gene3D; 3.60.20.10; Glutamine Phosphoribosylpyrophosphate, subunit 1, domain 1; 1. DR InterPro; IPR029055; Ntn_hydrolases_N. DR InterPro; IPR023332; Proteasome_alpha-type. DR InterPro; IPR000426; Proteasome_asu_N. DR InterPro; IPR001353; Proteasome_sua/b. DR PANTHER; PTHR11599:SF10; PROTEASOME SUBUNIT ALPHA TYPE-3; 1. DR PANTHER; PTHR11599; PROTEASOME SUBUNIT ALPHA/BETA; 1. DR Pfam; PF00227; Proteasome; 1. DR Pfam; PF10584; Proteasome_A_N; 1. DR SMART; SM00948; Proteasome_A_N; 1. DR SUPFAM; SSF56235; N-terminal nucleophile aminohydrolases (Ntn hydrolases); 1. DR PROSITE; PS00388; PROTEASOME_ALPHA_1; 1. DR PROSITE; PS51475; PROTEASOME_ALPHA_2; 1. DR World-2DPAGE; 0004:P18422; -. DR Genevisible; P18422; RN. PE 1: Evidence at protein level; KW 3D-structure; Acetylation; Cytoplasm; Direct protein sequencing; Nucleus; KW Phosphoprotein; Proteasome; Reference proteome. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000269|PubMed:2335242" FT CHAIN 2..255 FT /note="Proteasome subunit alpha type-3" FT /id="PRO_0000124093" FT MOD_RES 2 FT /note="N-acetylserine" FT /evidence="ECO:0000269|PubMed:2335242" FT MOD_RES 57 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P25788" FT MOD_RES 206 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P25788" FT MOD_RES 230 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P25788" FT MOD_RES 243 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:22673903" FT MOD_RES 250 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:16641100, FT ECO:0007744|PubMed:22673903" FT HELIX 22..32 FT /evidence="ECO:0007829|PDB:6TU3" FT STRAND 37..41 FT /evidence="ECO:0007829|PDB:6TU3" FT STRAND 46..53 FT /evidence="ECO:0007829|PDB:6TU3" FT STRAND 67..71 FT /evidence="ECO:0007829|PDB:6TU3" FT STRAND 74..80 FT /evidence="ECO:0007829|PDB:6TU3" FT HELIX 82..103 FT /evidence="ECO:0007829|PDB:6TU3" FT HELIX 109..121 FT /evidence="ECO:0007829|PDB:6TU3" FT HELIX 122..124 FT /evidence="ECO:0007829|PDB:6TU3" FT STRAND 127..129 FT /evidence="ECO:0007829|PDB:6TU3" FT STRAND 134..142 FT /evidence="ECO:0007829|PDB:6TU3" FT TURN 143..145 FT /evidence="ECO:0007829|PDB:6TU3" FT STRAND 146..152 FT /evidence="ECO:0007829|PDB:6TU3" FT STRAND 158..164 FT /evidence="ECO:0007829|PDB:6TU3" FT STRAND 167..169 FT /evidence="ECO:0007829|PDB:6TU3" FT HELIX 170..177 FT /evidence="ECO:0007829|PDB:6TU3" FT TURN 182..184 FT /evidence="ECO:0007829|PDB:6TU3" FT HELIX 187..201 FT /evidence="ECO:0007829|PDB:6TU3" FT STRAND 204..207 FT /evidence="ECO:0007829|PDB:6TU3" FT STRAND 210..218 FT /evidence="ECO:0007829|PDB:6TU3" FT TURN 219..223 FT /evidence="ECO:0007829|PDB:6TU3" FT HELIX 230..244 FT /evidence="ECO:0007829|PDB:6TU3" SQ SEQUENCE 255 AA; 28419 MW; F07FCB33A2E79FA7 CRC64; MSSIGTGYDL SASTFSPDGR VFQVEYAMKA VENSSTAIGI RCKDGVVFGV EKLVLSKLYE EGSNKRLFNV DRHVGMAVAG LLADARSLAD IAREEASNFR SNFGYNIPLK HLADRVAMYV HAYTLYSAVR PFGCSFMLGS YSVNDGAQLY MIDPSGVSYG YWGCAIGKAR QAAKTEIEKL QMKEMTCRDV VKEVAKIIYI VHDEVKDKAF ELELSWVGEL TKGRHEIVPK DVREEAEKYA KESLKEEDES DDDNM //